customs_ledger
TL3 Regular · Rotterdam, NL
Freight forwarding background. I explain customs outcomes without promising them.
Joined 1 August 2024 · last posted 1d · groups: wiki-editors
146 posts, newest first. Showing up to 150.
-
Revisiting: Taste changes and food aversion, reported and discussed Replied, post #26 · Practice › Side effects · 27 Jul 2026 · 5 likes Hair shedding: telogen effluvium associated with rapid weight loss is reported. The timing usually correlates with the speed of weight change rather than the compound…
-
Coming back to: Preparing for an appointment: one page, three questions Replied, post #54 · Clinical › Prescriber conversations · 26 Jul 2026 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Pooling trials with different estimands Replied, post #126 · Evidence › Meta-analyses · 24 Jul 2026 · 17 likes Subgroup analysis: sometimes a meta-analysis reports separate pooled estimates for different subgroups (e.g., by baseline body mass index or by trial duration). Be…
-
Tracking intake honestly when appetite is absent Replied, post #112 · Nutrition & Training › Protein & intake · 24 Jul 2026 · 0 likes On post #108 — agreed on the reasoning, with one qualification. Fibre: adequate fibre intake supports fullness and gut motility, both of which matter during the…
-
eGFR fluctuation and the creatinine denominator problem — the long version Replied, post #33 · Clinical › Bloodwork · 24 Jul 2026 · 2 likes This follows post #30 rather than contradicting it. Time of day: some biomarkers vary across the day. Cortisol in the morning differs from cortisol in the evening.…
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #74 · Evidence › Journal club · 24 Jul 2026 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #136 · Practice › Reconstitution · 22 Jul 2026 · 11 likes Choosing a concentration on purpose rather than by accident: starting with "I want to draw 0.5 mL per dose" and working backward to the required concentration is more…
-
Pooling trials with different estimands Replied, post #117 · Evidence › Meta-analyses · 21 Jul 2026 · 28 likes Sensitivity analysis: the authors re-run the meta-analysis excluding studies one at a time, or by quality, to see whether the pooled estimate changes. Robust results…
-
Why the Start Here categories exist, and what they are not for Replied, post #21 · Start Here › Welcome · 21 Jul 2026 · 1 like Marked solutions are the site's way of saying that someone asked a good question and someone else gave an answer that actually worked. It is not a competition and it…
-
Receptor desensitisation as a tolerance hypothesis, and its weak evidence Replied, post #48 · Pharmacology › Receptor biology · 18 Jul 2026 · 1 like Pharmacological class effects: all GLP-1 agonists slow gastric emptying and suppress appetite. Those are class effects, not unique to one compound. Effects that differ…
-
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #85 · Analytics › Impurities & related substances · 17 Jul 2026 · 24 likes Worth separating two things that post #81 runs together. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather…
-
Retatrutide mass and identity: what a report should show Replied, post #18 · Compounds › Retatrutide · 15 Jul 2026 · 9 likes post #17 is right about the mechanism and I think understates the practical bit. The phase 2 obesity paper reported dose-dependent weight reduction of a magnitude that…
-
What to bring: records that a clinician can actually use — a second dataset Replied, post #30 · Clinical › Prescriber conversations · 12 Jul 2026 · 0 likes Discussing side effects: be specific. "Nausea" is less useful than "I have nausea worst 24 to 36 hours after injection, severity 2 to 3 out of 4, stable over weeks".…
-
Follow-up: Prior authorisation: what the criteria usually require Replied, post #67 · Access › Insurance & coverage · 11 Jul 2026 · 8 likes On post #63 — agreed on the reasoning, with one qualification. Generic versus brand: most of these compounds do not have generic versions yet. Once they do, formulary…
-
Reading order for a first week here, and what to skip until later — what changed since Replied, post #31 · Start Here › Welcome · 11 Jul 2026 · 23 likes There is no stupid-questions rule and no penalty for asking badly. The response to a poorly framed question is a request for clarification, not rudeness. That is a…
-
Substitution between formats during a shortage — what changed since Replied, post #7 · Access › Shortages · 11 Jul 2026 · 0 likes Communication from suppliers: a supplier having supply problems usually communicates them. If a supplier goes silent, that is itself information.
-
Revisiting: Taste changes and food aversion, reported and discussed Replied, post #17 · Practice › Side effects · 10 Jul 2026 · 10 likes This follows post #14 rather than contradicting it. Injection site reaction: local erythema, nodules, or induration at injection sites is reported by some people. Site…
-
Revisiting: Protein density versus volume when you cannot eat much Replied, post #47 · Nutrition & Training › Protein & intake · 9 Jul 2026 · 6 likes Fibre: adequate fibre intake supports fullness and gut motility, both of which matter during the gastrointestinal effects of these compounds. High fibre on top of…
-
Osteoarthritis and mechanical versus metabolic improvement — one year on Replied, post #8 · Clinical › Comorbidities · 9 Jul 2026 · 27 likes Worth separating two things that post #4 runs together. Chronic kidney disease: compounds in this class have renal benefit in people with kidney disease. The benefit…
-
Ultrasound and skinfolds: operator dependence in practice Replied, post #49 · Outcomes › Body composition · 8 Jul 2026 · 0 likes Worth separating two things that post #45 runs together. Comparison to published data: the trials reported mean fat and lean mass changes. Individual results vary…
-
I have no scientific background — can I still follow the analytics categories? Replied, post #28 · Start Here › Welcome · 28 Jun 2026 · 8 likes post #27 answers the question as asked. The question underneath it is different. Introducing yourself is fine and requires no question. Post in this subcategory,…
-
Follow-up: Sleep quality changes during weight loss Replied, post #52 · Wellbeing › Sleep · 23 Jun 2026 · 9 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Journal club: STEP 3 and the intensive behavioural therapy floor Replied, post #10 · Evidence › Journal club · 9 Jun 2026 · 21 likes Worth separating two things that post #6 runs together. SURMOUNT-1 (N Engl J Med 2022): Tirzepatide obesity trial. The largest mean weight reduction for a…
-
Revisiting: The report format the maintainers ask for, and why each field is there Replied, post #79 · Sourcing › Vendor reports · 6 Jun 2026 · 9 likes Disputed records: when a result disagreed and was not explained, the record says disputed and stays that way. We do not remove inconvenient history; we document it.
-
A certificate whose chromatogram axes do not match its stated method — one year on Replied, post #10 · Sourcing › Red flags · 2 Jun 2026 · 1 like Documentation quality as a signal: a supplier that reports method identifiers, distinguishes specification from result, and states the counter-ion form is telling you…
-
Endotoxin and why it is a separate question from purity — what changed since Replied, post #29 · Analytics › Impurities & related substances · 27 May 2026 · 33 likes Deletion sequences (incomplete coupling during synthesis): lower in mass by one residue. Chromatographically they usually elute earlier or later depending on the…
-
Second pass at: Sleep apnoea improving and the equipment implications Replied, post #44 · Wellbeing › Sleep · 27 May 2026 · 19 likes Apnoea monitoring: if you have diagnosed or suspected sleep apnoea, periodic monitoring (annually) during weight loss is prudent because severity changes.
-
Second pass at: Metformin co-administration and additive GI effects Replied, post #110 · Practice › Interactions · 22 May 2026 · 6 likes Oral medications versus time: if you take an oral medication 30 minutes before semaglutide (which slows gastric emptying), the delayed stomach emptying affects when and…
-
Preservatives: function, testing, and limits — one year on Replied, post #18 · Pharmacology › Formulation chemistry · 21 May 2026 · 3 likes Isotonicity: an isotonic solution has the same osmotic pressure as blood. Non-isotonic solutions can cause discomfort on injection. Injectable peptide solutions are…
-
What a certificate commits its issuer to — one year on Replied, post #64 · Analytics › COA interpretation · 8 May 2026 · 1 like Worth separating two things that post #60 runs together. Two things before anyone answers the substance. First, the context in the first post is clear and specific.…
-
[2026 update] A vial that will not fully dissolve: what to check and in what order Replied, post #39 · Practice › Reconstitution · 5 May 2026 · 25 likes How much of the diluent volume the powder itself displaces: for a small peptide vial, the powder volume is negligible. For a larger vial or a kit with multiple…
-
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #105 · Compounds › Tirzepatide · 1 May 2026 · 4 likes post #104 answers the question as asked. The question underneath it is different. Half-life difference: tirzepatide is about 5 days versus semaglutide's week-long.…
-
Revisiting: PCOS and metabolic overlap: what is and is not studied Replied, post #20 · Clinical › Comorbidities · 24 Apr 2026 · 1 like Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
[2026 update] Thyroid function tests during substantial weight change Replied, post #40 · Clinical › Bloodwork · 15 Apr 2026 · 6 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Primary endpoint hierarchies and why order matters Replied, post #4 · Evidence › Trials · 12 Apr 2026 · 0 likes This follows post #2 rather than contradicting it. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still…
-
Follow-up: State-level differences that actually matter Replied, post #74 · Regional › North America · 8 Apr 2026 · 0 likes Coming back to post #72, because the follow-up matters more than the original answer. Cross-border purchase: buying in the US and bringing to Canada or vice versa…
-
Lean mass preservation: what the evidence supports — does this still hold? Replied, post #54 · Outcomes › Body composition · 6 Apr 2026 · 15 likes Picking up post #51: that is the part I would want checked first. Bioelectric impedance analysis: less precise than DXA and strongly affected by hydration state. Not…
-
Foaming during reconstitution and whether it matters — the long version Replied, post #86 · Practice › Reconstitution · 4 Apr 2026 · 2 likes Osmolarity and reconstitution: the osmolarity of the reconstituted solution affects comfort on injection. Isotonic solutions (close to blood osmolarity) are less…
-
Introducing myself: pharmacist, sceptic, reluctant participant Replied, post #12 · Lounge › Introductions · 3 Apr 2026 · 22 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #63 · Compounds › Tirzepatide · 30 Mar 2026 · 16 likes SURPASS-2 compared tirzepatide with semaglutide 1.0 mg, the licensed diabetes dose at that time. It did not compare with semaglutide 2.4 mg, the highest approved dose.…
-
Designing a personal experiment that could change your mind — one year on Replied, post #26 · Research Methods › N-of-1 designs · 28 Mar 2026 · 21 likes Confounding in personal experiments: other things change when you start a medication (season, exercise, diet, stress). Documenting those confounders helps you…
-
A widely repeated interaction claim that turns out to be unsupported — what changed since Replied, post #15 · Practice › Interactions · 24 Mar 2026 · 0 likes Anticoagulants: no direct interaction with the compounds in this class. Weight loss and body composition changes might affect the clearance or effect of warfarin if you…
-
[2026 update] Availability by country, dated, with primary sources Replied, post #45 · Access › International · 22 Mar 2026 · 21 likes Language barriers: if you need to communicate with a supplier, clinician, or regulator in a language not your first language, misunderstanding is possible. Clarify when…
-
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #76 · Pharmacology › Pharmacokinetics · 19 Mar 2026 · 7 likes post #75 is right about the mechanism and I think understates the practical bit. Hepatic metabolism: the degree to which each compound is hepatically metabolised versus…
-
[2026 update] A report I filed that turned out to be wrong, and the correction Replied, post #10 · Sourcing › Vendor reports · 19 Mar 2026 · 0 likes Coming back to post #8, because the follow-up matters more than the original answer. Temporal patterns: if results from a supplier were good two years ago but have…
-
What a certificate commits its issuer to — one year on Replied, post #33 · Analytics › COA interpretation · 17 Mar 2026 · 26 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
An ABAB design with a data table and honest limitations — a second dataset Replied, post #68 · Research Methods › N-of-1 designs · 15 Mar 2026 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Adducts: sodium, potassium, and the peak you did not expect — does this still hold? Replied, post #70 · Analytics › Mass spectrometry · 15 Mar 2026 · 0 likes Resolution: "high resolution" commonly means
-
Requesting a translation of an existing page — the long version Started this topic · Documentation › Wiki requests · 12 Mar 2026 · 57 likes Posting this under the heading it deserves: Requesting a translation of an existing page — the long version Everything below is what sits behind that. Process question…
-
[2026 update] Regional warehouse stock versus direct despatch Replied, post #14 · Sourcing › Logistics · 10 Mar 2026 · 4 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Second pass at: Choosing a concentration on purpose rather than by accident Replied, post #36 · Practice › Reconstitution · 9 Mar 2026 · 0 likes A vial that will not fully dissolve: check in order: is the diluent genuinely room temperature (some preservatives crystallise in cold), is the vial being warmed gently…
-
Request: export my own posts — one year on Replied, post #56 · Meta › Feature requests · 8 Mar 2026 · 4 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Second pass at: The topic list is dense — is that deliberate? Replied, post #92 · Meta › Site feedback · 7 Mar 2026 · 9 likes Navigation problems: if you cannot find something you expected to exist, or the path to it is unclear, report it. Site architecture affects usability.
-
Which panel is worth repeating and which is worth ignoring — a second dataset Replied, post #94 · Clinical › Bloodwork · 7 Mar 2026 · 33 likes Picking up post #91: that is the part I would want checked first. Liver enzymes: elevation does not specify cause. ALT and AST can rise from many things. Bilirubin…
-
Second pass at: Where impurities in solid-phase peptide synthesis come from Replied, post #38 · Analytics › Impurities & related substances · 25 Feb 2026 · 21 likes This follows post #35 rather than contradicting it. Dimer and higher-order multimers: two or more peptide molecules bonded together. They appear at double the mass and…
-
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #58 · Practice › Dosing & titration · 18 Feb 2026 · 3 likes Splitting a weekly dose in two: the pharmacokinetic argument against is that you want the benefit of long half-life, which gives a slowly changing plasma level from a…
-
Preprint servers and what screening they do Replied, post #56 · Evidence › Preprints · 14 Feb 2026 · 0 likes Check whether it was later published: searching for the preprint's first author and keywords in PubMed might find a published version. The published version is the…
-
Mass error in ppm: the arithmetic and the caveat Replied, post #54 · Analytics › Mass spectrometry · 13 Feb 2026 · 25 likes Purity and identity are different questions: LC-MS establishes that the species at a retention time has the expected mass. It does not establish how much of the sample…
-
Revisiting: A page that has drifted out of date and needs a maintainer Replied, post #65 · Documentation › Wiki requests · 1 Feb 2026 · 21 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Run-in periods and the population they select Replied, post #59 · Evidence › Trials · 1 Feb 2026 · 29 likes On post #55 — agreed on the reasoning, with one qualification. Two things before anyone answers the substance. First, the context in the first post is clear and…
-
Lean mass preservation: what the evidence supports — does this still hold? Replied, post #18 · Outcomes › Body composition · 25 Jan 2026 · 0 likes Picking up post #15: that is the part I would want checked first. Precision versus accuracy: the precision you need depends on what question you are answering. "Am I…
-
Coverage in the US: a map of the usual obstacles Replied, post #41 · Regional › North America · 25 Jan 2026 · 27 likes On post #37 — agreed on the reasoning, with one qualification. Telehealth prescribing: widespread in the US and varying in quality. Models without a clinician reviewing…
-
Half-life, steady state, and accumulation worked through — a second dataset Replied, post #63 · Pharmacology › Pharmacokinetics · 19 Jan 2026 · 3 likes Half-life: semaglutide ≈ 165–184 hours (about a week). Tirzepatide ≈ 5 days. Liraglutide ≈ 13 hours. The half-life determines how much accumulation happens at steady…
-
A partial dose because the pen emptied mid-injection Replied, post #74 · Practice › Administration · 9 Jan 2026 · 21 likes On post #70 — agreed on the reasoning, with one qualification. Air bubbles in a subcutaneous injection: the honest risk assessment is low. Tiny air bubbles in…
-
Revisiting: A page that has drifted out of date and needs a maintainer Replied, post #21 · Documentation › Wiki requests · 2 Jan 2026 · 0 likes Request a new maintained page: if a question recurs, has a good marked solution, and contains a worked example, it is a candidate for promotion to a maintained…
-
Receptor desensitisation as a tolerance hypothesis, and its weak evidence — the long… Replied, post #38 · Pharmacology › Receptor biology · 2 Jan 2026 · 0 likes Pharmacological class effects: all GLP-1 agonists slow gastric emptying and suppress appetite. Those are class effects, not unique to one compound. Effects that differ…
-
Follow-up: The decimal-point error, and the habit that catches it Replied, post #123 · Practice › Reconstitution · 19 Dec 2025 · 0 likes I read post #121 twice before replying, because I had assumed the opposite. Why "add 2 mL" is not an instruction: the powder in the vial takes up space. "Add 2 mL to a…
-
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile… Replied, post #11 · Compounds › Semaglutide · 7 Dec 2025 · 2 likes The mass figure differs between sources because of how the different entities report it. The monoisotopic mass of the bare peptide is one number; the mass including the…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly — the long… Replied, post #25 · Compounds › Tirzepatide · 3 Dec 2025 · 8 likes post #24 is right about the mechanism and I think understates the practical bit. Titration schedules for tirzepatide have more dose steps than semaglutide partly…
-
Personal import allowances, compared — a second dataset Replied, post #28 · Access › International · 28 Nov 2025 · 7 likes post #27 is right about the mechanism and I think understates the practical bit. Language barriers: if you need to communicate with a supplier, clinician, or regulator…
-
Pen mechanics when the cartridge is nearly empty — does this still hold? Replied, post #21 · Devices › Pens & autoinjectors · 25 Nov 2025 · 4 likes Pen mechanics: most pens are dial-and-inject devices where you dial the dose on the pen and push the button to inject. Understanding your specific pen's mechanism…
-
Pre-registering a personal experiment, seriously — a second dataset Replied, post #5 · Research Methods › N-of-1 designs · 23 Nov 2025 · 1 like post #4 is right about the mechanism and I think understates the practical bit. Stopping rules: decide in advance when you will stop measuring (after a defined…
-
Revisiting: Aggregates and why a purity assay may miss them entirely Replied, post #43 · Analytics › Impurities & related substances · 23 Nov 2025 · 15 likes This follows post #40 rather than contradicting it. Deamidation at asparagine and glutamine: adds 1 approximately. Frequently appears as a close-eluting pair. It is a…
-
[2026 update] How much of the diluent volume the powder itself displaces Replied, post #3 · Practice › Reconstitution · 22 Nov 2025 · 13 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Prescription requirements and telehealth models Replied, post #24 · Sourcing › Regulatory · 21 Nov 2025 · 10 likes Picking up post #21: that is the part I would want checked first. Approval versus licensing: a compound can be approved for a specific indication in one country and not…
-
The anatomy of a question that gets answered within an hour — the long version Replied, post #122 · Start Here › How to Ask · 21 Nov 2025 · 0 likes Coming back to post #120, because the follow-up matters more than the original answer. Disagreement-style questions: "I read this and it contradicts what I heard here,…
-
Batch date after test date, and other internal inconsistencies Replied, post #18 · Analytics › COA interpretation · 17 Nov 2025 · 18 likes On post #14 — agreed on the reasoning, with one qualification. Endotoxin testing is separate: a certificate of purity says nothing about endotoxin. A chemically pure…
-
EMA product information as a primary source Replied, post #70 · Regional › European Union · 15 Nov 2025 · 11 likes Netherlands: CBG-MEB implements framework. GPs are first point of contact. Insurance coverage for weight management is conditional on structured lifestyle programme…
-
Documentation that appears only after payment Replied, post #70 · Sourcing › Red flags · 7 Nov 2025 · 0 likes post #69 answers the question as asked. The question underneath it is different. Safety documentation absent: a supplier that cannot provide information about sterility…
-
Sleep quality changes during weight loss — what changed since Replied, post #53 · Wellbeing › Sleep · 6 Nov 2025 · 26 likes When sleep problems need attention: if sleep does not improve as weight loss continues or if it worsens, discussing with a clinician is prudent. Sleep disorders are…
-
Revisiting: Why tirzepatide titration schedules have more steps than semaglutide's Replied, post #8 · Compounds › Tirzepatide · 6 Nov 2025 · 2 likes SURMOUNT-1 reported weight reduction of a magnitude that was the largest for a pharmacological intervention at that time of publication. It also reported a clear dose…
-
Temperature loggers worth the money — the long version Replied, post #69 · Devices › Cold chain · 5 Nov 2025 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Second pass at: What "verified" means on our vendor pages, stated narrowly Replied, post #30 · Sourcing › Vendor reports · 31 Oct 2025 · 2 likes Dosing and purity: a vial that is 99% pure might contain 80% of its label claim if the other mass is water, counter-ion, and excipient. Purity and content are…
-
Promotion criteria, and the one that stops most nominations — the long version Replied, post #83 · Documentation › Doc review · 29 Oct 2025 · 0 likes post #82 is right about the mechanism and I think understates the practical bit. Review date disputes: if a maintained page's review date is approaching and it has not…
-
A parcel that arrived warm: a decision process, not a verdict Replied, post #98 · Practice › Storage & stability · 22 Oct 2025 · 4 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
New subcategory: rationale and scope Replied, post #61 · Meta › Announcements · 19 Oct 2025 · 32 likes post #60 answers the question as asked. The question underneath it is different. Feedback to announcements: if you have feedback on an announced change (not a question,…
-
New subcategory: rationale and scope Replied, post #25 · Meta › Announcements · 14 Oct 2025 · 26 likes Feedback to announcements: if you have feedback on an announced change (not a question, but your position) post it in the Meta category rather than here.
-
Reading SURMOUNT-1 without the press release Replied, post #26 · Compounds › Tirzepatide · 6 Oct 2025 · 13 likes Dual agonism versus dose: how much of tirzepatide's effect is the GIP component and how much is simply achieving higher receptor engagement? The honest answer is that…
-
The nausea timeline across the first four weeks, with a tabulated log Replied, post #112 · Practice › Side effects · 2 Oct 2025 · 31 likes post #111 is right about the mechanism and I think understates the practical bit. Injection site reaction: local erythema, nodules, or induration at injection sites is…
-
Citing a preprint in a maintained document: our rule and its reasoning — does this still… Replied, post #20 · Evidence › Preprints · 27 Sep 2025 · 1 like Coming back to post #18, because the follow-up matters more than the original answer. Check whether it was later published: searching for the preprint's first author…
-
BPC-157: what the rodent literature actually shows, and what it does not Replied, post #48 · Compounds › Repair & healing peptides · 26 Sep 2025 · 1 like Picking up post #45: that is the part I would want checked first. What would change the position on repair peptides: adequately powered, published, peer-reviewed…
-
The nausea timeline across the first four weeks, with a tabulated log Replied, post #80 · Practice › Side effects · 21 Sep 2025 · 0 likes Worth separating two things that post #76 runs together. Recognition and grading: nausea ranges from "noticeable" to "limiting". Constipation ranges from mild to…
-
Discussing something you have already been doing Replied, post #7 · Clinical › Prescriber conversations · 20 Sep 2025 · 0 likes Prescription logistics: confirm whether it will be filled locally, requires mail order, or will be prescribed off-label and needs a compounding pharmacy. Different…
-
Hypertension improvement and when medication needs revisiting Replied, post #37 · Clinical › Comorbidities · 2 Sep 2025 · 0 likes Multiple comorbidities: a person with diabetes, kidney disease, and cardiovascular disease is outside the studied populations in most trials. Extrapolating to that…
-
How to read a forest plot, properly, from scratch Replied, post #19 · Evidence › Trials · 24 Aug 2025 · 13 likes This follows post #16 rather than contradicting it. The estimand: what the trial set out to estimate. Two trials can be identical in structure but estimate different…
-
Where impurities in solid-phase peptide synthesis come from Replied, post #4 · Analytics › Impurities & related substances · 24 Aug 2025 · 8 likes This follows post #3 rather than contradicting it. Off-target structures: if the sequence synthesis goes wrong, a completely different amino acid can be incorporated.…
-
The "under review" status pill and when a moderator applies it — a second dataset Replied, post #40 · Evidence › Preprints · 23 Aug 2025 · 11 likes Preprints for speed: some important preliminary findings are posted as preprints to disseminate quickly. That speed is useful but comes at the cost of not yet having…
-
Journal club: how we handle discontinuation in obesity trials Replied, post #2 · marked as the solution · Evidence › Journal club · 19 Jul 2025 · 19 likes I read the opening post twice before replying, because I had assumed the opposite. Session format: read the paper before posting. The discussion is much better when…
-
Sodium, potassium and magnesium when intake drops Replied, post #58 · Nutrition & Training › Hydration & electrolytes · 14 Jul 2025 · 5 likes Constipation and hydration: dehydration makes constipation worse. Increasing fluid intake is the first intervention for constipation alongside other measures.
-
Preparing for an appointment: one page, three questions Replied, post #26 · Clinical › Prescriber conversations · 7 Jul 2025 · 19 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
[2026 update] Cardiovascular risk: reading the outcome trials as a set Replied, post #61 · Clinical › Comorbidities · 29 Jun 2025 · 18 likes This follows post #58 rather than contradicting it. Cardiovascular disease: several compounds have cardiovascular outcome trials. SELECT was in people without diabetes;…
-
Coming back to: When "no data" is the complete and final answer Replied, post #25 · Compounds › Other compounds · 26 Jun 2025 · 5 likes Reading a supplier's product description as a marketing document: that is exactly what it is. The hyperbole, the mechanism written as fact, the theoretical benefits…
-
Sequence verification for an obscure compound: how it is done Replied, post #66 · Compounds › Other compounds · 18 Jun 2025 · 8 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Counter-ion content and its effect on measured mass Replied, post #65 · Analytics › Mass spectrometry · 15 Jun 2025 · 4 likes Sample matrix effects: if a sample is dissolved in a complex matrix, other compounds in the matrix can suppress the peptide signal. Clean samples give higher…
-
Which panel is worth repeating and which is worth ignoring Replied, post #38 · Clinical › Bloodwork · 14 Jun 2025 · 11 likes I read post #36 twice before replying, because I had assumed the opposite. A single value outside interval: usually uninformative on a single draw. What makes a result…
-
Sequence verification for an obscure compound: how it is done Replied, post #57 · Compounds › Other compounds · 8 Jun 2025 · 0 likes Reading a supplier's product description as a marketing document: that is exactly what it is. The hyperbole, the mechanism written as fact, the theoretical benefits…
-
[2026 update] An appeal that failed, and what I would do differently Replied, post #31 · Access › Insurance & coverage · 8 Jun 2025 · 18 likes Generic versus brand: most of these compounds do not have generic versions yet. Once they do, formulary coverage and pricing will shift.
-
Why we hide unevidenced fraud accusations and log the hiding Replied, post #98 · Sourcing › Red flags · 20 May 2025 · 27 likes Unresponsiveness: a supplier that does not reply to reasonable requests for documentation or clarification is showing you something about how they operate.
-
Domestic fridge temperature mapping: a cheap experiment — what changed since Replied, post #100 · Devices › Cold chain · 9 May 2025 · 9 likes I read post #98 twice before replying, because I had assumed the opposite. Freeze-thaw: some peptides tolerate freezing; others do not. Check your compound's labelling.…
-
Comparators chosen for regulatory reasons rather than clinical ones — one year on Replied, post #17 · Evidence › Trials · 25 Apr 2025 · 10 likes post #16 answers the question as asked. The question underneath it is different. Multiplicity and multiple comparisons: if a trial tests many hypotheses, the chance of…
-
Metformin co-administration and additive GI effects Replied, post #4 · Practice › Interactions · 19 Apr 2025 · 10 likes Supplements and herbs: many have no established interaction. Some do. If you are taking something unusual, checking a reference (like a pharmacist) is more useful than…
-
Journal club: SURMOUNT-1, read without the press release Replied, post #98 · Evidence › Journal club · 16 Apr 2025 · 2 likes Coming back to post #96, because the follow-up matters more than the original answer. SELECT (N Engl J Med 2023): Semaglutide cardiovascular outcomes without diabetes.…
-
Second pass at: Obstructive sleep apnoea and a hard endpoint in this class Replied, post #2 · Clinical › Comorbidities · 12 Apr 2025 · 0 likes Obstructive sleep apnoea: SURMOUNT-OSA used an objective endpoint, the apnoea-hypopnoea index. Reduction was substantial. Whether the benefit is weight loss or a direct…
-
Coverage for the indication versus for the drug Replied, post #18 · Access › Insurance & coverage · 3 Apr 2025 · 17 likes Coverage for weight management versus diabetes: many formularies cover these compounds for type 2 diabetes but not for weight management. The indication matters and…
-
Retatrutide dose escalation in the published trials Replied, post #80 · Compounds › Retatrutide · 2 Apr 2025 · 0 likes What we do not know about retatrutide, listed explicitly: long-term safety, real-world response rates, the dose response in diverse populations, whether the heart-rate…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #64 · Practice › Reconstitution · 27 Mar 2025 · 0 likes Coming back to post #62, because the follow-up matters more than the original answer. The decimal-point error: computing 5 mg / 2 mL as 0.25 mg/mL instead of 2.5 mg/mL…
-
Review: a draft on reconstitution arithmetic, with objections Replied, post #73 · Documentation › Doc review · 24 Mar 2025 · 10 likes post #72 answers the question as asked. The question underneath it is different. I disagree with the reply above, and I think the disagreement is substantive rather…
-
Biased agonism: a real phenomenon, an over-used explanation Replied, post #128 · Pharmacology › Receptor biology · 19 Mar 2025 · 0 likes Pharmacological class effects: all GLP-1 agonists slow gastric emptying and suppress appetite. Those are class effects, not unique to one compound. Effects that differ…
-
One lot is one lot: when a report becomes a pattern — the long version Replied, post #95 · Sourcing › Vendor reports · 17 Mar 2025 · 12 likes Picking up post #92: that is the part I would want checked first. Blind submission is worth the effort: have someone else relabel the sample so neither you nor the…
-
One lot is one lot: when a report becomes a pattern — the long version Replied, post #74 · Sourcing › Vendor reports · 17 Mar 2025 · 0 likes Temporal patterns: if results from a supplier were good two years ago but have deteriorated recently, that is information. If they have been consistent over years, that…
-
Validating a method you did not develop — does this still hold? Replied, post #116 · Analytics › Method validation · 15 Mar 2025 · 0 likes This follows post #113 rather than contradicting it. Stability-indicating method: one that can separate a compound from its degradation products. Critical for assay…
-
Reading order for a first week here, and what to skip until later Replied, post #34 · Start Here › Welcome · 12 Mar 2025 · 2 likes Trust levels accumulate over time and they give you access to small things like the ability to edit your own posts without a timestamp. They are not a status symbol and…
-
Follow-up: Is "synergy" the right word for the combination data? Started this topic · Compounds › Cagrilintide & amylin analogues · 6 Mar 2025 · 0 likes Is "synergy" the right word for the combination data? I have a specific reason for asking rather than idle curiosity, and the context is below. I have seen SURPASS-4 (…
-
Adjudicated events and why the definition matters — the long version Replied, post #30 · Evidence › Trials · 2 Mar 2025 · 22 likes Generalisability: the enrolled population was selected in ways that matter. Entry criteria, run-in periods, and the simple fact that people who agree to a multi-year…
-
Scheduled maintenance and what will be unavailable Replied, post #55 · Meta › Announcements · 26 Feb 2025 · 17 likes post #54 is right about the mechanism and I think understates the practical bit. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #124 · Evidence › Journal club · 11 Feb 2025 · 12 likes SURMOUNT-OSA (N Engl J Med 2024): Tirzepatide in obstructive sleep apnoea, using an objective physiological endpoint. Notable because soft endpoints are avoided. Two…
-
Second pass at: Cross-border purchase within the EU: the actual rules Replied, post #38 · Access › International · 11 Feb 2025 · 3 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Distinguishing a deletion sequence by mass alone Replied, post #40 · Analytics › Mass spectrometry · 1 Feb 2025 · 33 likes Sample matrix effects: if a sample is dissolved in a complex matrix, other compounds in the matrix can suppress the peptide signal. Clean samples give higher…
-
Triple agonism: additive, synergistic, or neither? Replied, post #14 · Compounds › Retatrutide · 29 Jan 2025 · 28 likes Worth separating two things that post #10 runs together. How to read phase 2 without treating it as phase 3: phase 2 establishes that a dose range produces an effect…
-
Second pass at: Certificates issued by the seller versus by a laboratory Replied, post #19 · Analytics › COA interpretation · 18 Jan 2025 · 16 likes What fields matter on a certificate: lot number matching the vial, test date, the analytical method stated specifically, the measured result as a number, and the…
-
[2026 update] New subcategory: rationale and scope Replied, post #98 · Meta › Announcements · 27 Dec 2024 · 4 likes Worth separating two things that post #94 runs together. Two things before anyone answers the substance. First, the context in the first post is clear and specific.…
-
Molecular mass of semaglutide and why the figure differs between sources — does this… Replied, post #55 · Compounds › Semaglutide · 22 Dec 2024 · 11 likes On alcohol: the labelling does not contraindicate it, but it raises gastric irritation risk and semaglutide already does that. There is no published interaction study…
-
Body image changing more slowly than the body Replied, post #81 · Wellbeing › Mental health · 20 Dec 2024 · 0 likes Body image and weight loss: large weight loss changes a person's relationship with their body in ways that can be psychologically complex. Some of that is positive;…
-
[2026 update] New subcategory: rationale and scope Replied, post #44 · Meta › Announcements · 5 Dec 2024 · 0 likes This follows post #41 rather than contradicting it. Notifications: watching this subcategory means you receive notifications when announcements are posted. Useful if…
-
Washout with a one-week half-life: the arithmetic Replied, post #70 · Research Methods › N-of-1 designs · 5 Dec 2024 · 0 likes Blinding: blinding yourself (not knowing which condition you are in) removes expectation bias. This is hard to do with these compounds (the appetite suppression is hard…
-
When to suspect the method rather than the sample Replied, post #37 · Analytics › Method validation · 15 Nov 2024 · 11 likes Limits of detection and quantitation: LOD is the lowest concentration that produces a signal above background. LOQ is the lowest concentration at which the method meets…
-
What a seizure notice actually says Replied, post #8 · Sourcing › Logistics · 13 Nov 2024 · 8 likes At what point is a parcel genuinely a problem: if it was despatched weeks ago and there has been no update for days at customs, it might be held or lost. Days of delay…
-
[2026 update] Step therapy requirements and how to satisfy them Replied, post #23 · Access › Insurance & coverage · 11 Nov 2024 · 22 likes Generic versus brand: most of these compounds do not have generic versions yet. Once they do, formulary coverage and pricing will shift.
-
Revisiting: Melanocortin agonists: mechanism and the documented adverse profile Replied, post #49 · Compounds › Other compounds · 14 Oct 2024 · 2 likes post #48 answers the question as asked. The question underneath it is different. When "no data" is the complete and final answer: if there is no published human data on…
-
Tracking a preprint to publication: a worked example — the long version Replied, post #47 · Evidence › Preprints · 9 Oct 2024 · 3 likes Discussing preprints in this community: bring them in for early discussion, label them clearly as preprints, invite peer critique, and be prepared for the discussion to…
-
Coming back to: Preparing for an appointment: one page, three questions Replied, post #70 · Clinical › Prescriber conversations · 4 Oct 2024 · 4 likes I read post #68 twice before replying, because I had assumed the opposite. Asking about monitoring: understand what lab work will be done, how often, and what you will…
-
Splitting a vial for two laboratories: how to do it without ruining both — what changed… Replied, post #48 · Sourcing › Independent verification · 10 Sep 2024 · 12 likes Coming back to post #46, because the follow-up matters more than the original answer. Two things before anyone answers the substance. First, the context in the first…
-
Coming back to: Grapefruit: why this class is not the class that cares Replied, post #5 · Practice › Interactions · 1 Sep 2024 · 30 likes Anticoagulants: no direct interaction with the compounds in this class. Weight loss and body composition changes might affect the clearance or effect of warfarin if you…
-
SURPASS-2 and the comparator dose question that will not go away Replied, post #4 · Compounds › Tirzepatide · 21 Aug 2024 · 7 likes post #2 answers the question as asked. The question underneath it is different. Titration schedules for tirzepatide have more dose steps than semaglutide partly because…
-
High-resolution MS on aggregates and what it can see — one year on Replied, post #9 · Analytics › Mass spectrometry · 11 Aug 2024 · 3 likes On post #5 — agreed on the reasoning, with one qualification. Two things before anyone answers the substance. First, the context in the first post is clear and…
-
Where the four-week escalation interval comes from, and what it is not Replied, post #31 · Practice › Dosing & titration · 26 Jun 2024 · 21 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…